Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies

SIMPLE SUMMARY: Despite the adoption of aggressive, multimodal treatment schedules, the cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 years. The most relevant problem preventing improvement in HGOS prognosis is drug resistance. Therefore, validated novel b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattinger, Claudia Maria, Patrizio, Maria Pia, Fantoni, Leonardo, Casotti, Chiara, Riganti, Chiara, Serra, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228414/
https://www.ncbi.nlm.nih.gov/pubmed/34207685
http://dx.doi.org/10.3390/cancers13122878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228414/
https://www.ncbi.nlm.nih.gov/pubmed/34207685
http://dx.doi.org/10.3390/cancers13122878

Ejemplares similares